COGT Stock-Based Compensation
Cogent Biosciences Inc · Stock-Based Compensation
COGT Stock-Based Compensation
Latest reported$60.37Mperiod ending
COGT Stock-Based Comp ($248.00K → $60.37M)
Annual stock-based compensation
High-resolution chart · PNG
COGT stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 46,079,000 | |
| 39,740,000 | |
| 30,621,000 | |
| 18,368,000 | |
| 11,686,000 | |
| 6,017,000 | |
| 3,241,000 | |
| 3,088,000 | |
| 1,341,000 | |
| 1,016,000 | |
| 248,000 |